Cited by 28Neuroscience and Neuropharmacology ResearchReceptor Mechanisms and SignalingNeurotransmitter Receptor Influence on Behavior

Hippocampal 5‐HT7receptors signal phosphorylation of the GluA1 subunit to facilitate AMPA receptor mediated‐neurotransmission in vitro and in vivo

Open access
Andreetta, Filippo, Carboni, Lucia, Grafton, Gillian, Jeggo, Ross, Whyment, Andrew D, van den Top, Marco, Hoyer, Daniel, Spanswick, David +1 more·2016·British Journal of Pharmacology

Abstract

Background and Purpose: The 5‐HT 7 receptor is a GPCR that is the target of a broad range of antidepressant and antipsychotic drugs. Various studies have demonstrated an ability of the 5‐HT 7 receptor to modulate glutamatergic neurotransmission and cognitive processes although the potential impact upon AMPA receptors has not been investigated directly. The purposes of the present study were to investigate a direct modulation of the GluA1 AMPA receptor subunit and determine how this might influence AMPA receptor function. Experimental Approach: The influence of pharmacological manipulation of the 5‐HT 7 receptor system upon phosphorylation of GluA1 subunits was assessed by Western blotting of fractionated proteins from hippocampal neurones in culture (or proteins resident at the neurone surface) and the functional impact assessed by electrophysiological recordings in rat hippocampus in vitro and in vivo. Key Results: 5‐HT 7 receptor activation increased cAMP and relative pCREB levels in cultures of rat hippocampal neurones along with an increase in phosphorylation (Ser845) of the GluA1 AMPA receptor subunit evident in whole neurone extracts and within the neurone surface compartment. Electrophysiological recordings in rat hippocampus demonstrated a 5‐HT 7 receptor‐mediated increase in AMPA receptor‐mediated neurotransmission in vitro and in vivo. Conclusions and Implications: The 5‐HT 7 receptor‐mediated phosphorylation of the GluA1 AMPA receptor provides a molecular mechanism consistent with the 5‐HT 7 receptor‐mediated increase in AMPA receptor‐mediated neurotransmission.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bph.13432

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Authors
Andreetta, F., Carboni, L., Grafton, G., Jeggo, R., Whyment, A. D., van den Top, M., Hoyer, D., Spanswick, D., & Barnes, N. M.
Affiliations
  • GlaxoSmithKline (Italy) (IT)
  • University of Birmingham (GB)
  • NeuroSolutions Limited Coventry UK
  • Department of Pharmacology and Therapeutics, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences The University of Melbourne Parkville Vic. Australia
  • The University of Melbourne (AU)
Corresponding author
Barnes, Nicholas M
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2016-03-21
Volume
173
Issue
9
Pages
1438-1451
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2235125632
Cited by
28
References
70
Citations by year
2026: 5 · 2025: 2 · 2023: 1 · 2022: 2 · 2021: 3 · 2020: 2 · 2019: 1 · 2018: 5 · 2017: 6 · 2016: 1
FWCI
2.44
Type
journal article
Language
en
Open access
Locations
  • British Journal of Pharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
5-HT7 receptor, GluA1 subunit, AMPA receptors, receptor phosphorylation, hippocampus, glutamatergic neurotransmission, cAMP signaling, CREB, serotonin receptors, G protein-coupled receptors
MeSH terms
Animals, Hippocampus, Synaptic Transmission, Phosphorylation, Receptors, Serotonin, Receptors, AMPA, Protein Subunits, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review